Functional characterization of the progestagen-associated endometrial protein gene in human melanoma

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1432-1442

  Ren, Suping ^a   Liu, Suhu ^b   Howell, Paul M ^a   Zhang, Guangyu ^a   Pannell, Lewis ^a   Samant, Rajeev ^a   Shevde Samant, Lalita ^a   Tucker, J Allan ^c   Fodstad, Oystein ^a,d   Riker, Adam I ^e  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Ochsner Cancer Institute   (United States)

Author keywords

Melanoma; Oncogene; Progestagen associated endometrial protein; RNA interference

Indexed keywords

AGAR; GLYCOPROTEIN; PAEP PROTEIN, HUMAN; PLACENTA PROTEIN; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; CANCER INVASION; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LENTIVIRINAE; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; REPRODUCIBILITY; SKIN TUMOR; TUMOR CELL LINE;

AGAR; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GLYCOPROTEINS; HUMANS; LENTIVIRUS; MELANOMA; MICE; NEOPLASM INVASIVENESS; PREGNANCY PROTEINS; REPRODUCIBILITY OF RESULTS; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE;

EID: 77955154592     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00922.x     Document Type: Article

References (40)

1. Seppälä M, Taylor RN, Koistinen H. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev. 2002, 23:401-30.
2. Julkunen M, Rutanen EM, Koskimies A. Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol. 1985, 92:1145-51.
3. Morrow DM, Xiong N, Getty RR. Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol. 1994, 145:1485-95.
4. Rachmilewitz J, Riely GJ, Huang JH. A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds. Blood. 2001, 98:3727-32.
5. Yaniv E, Borovsky Z, Mishan-Eisenberg G. Placental protein 14 regulates selective B cell responses. Cell Immunol. 2003, 222:156-63.
6. Okamoto N, Uchida A, Takakura K. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol. 1991, 26:137-42.
7. Vigne JL, Hornung D, Mueller MD. Purification and characterization of an immunomodulatory endometrial protein, glycodelin. J Biol Chem. 2001, 276:17101-5.
8. Oehninger S, Coddington CC, Hodgen GD. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril. 1995, 63:377-83.
9. Jeschke U, Kuhn C, Mylonas I. Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues. Histopathology. 2006, 48:394-406.
10. Mandelin E, Lassus H, Seppälä M. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res. 2003, 63:6258-64.
11. Shabani N, Mylonas I, Kunert-Keil C. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases. Anticancer Res. 2005, 25:1761-4.
12. Connor JP, Brudney A, Ferrer K. Glycodelin-A expression in the uterine cervix. Gynecol Oncol. 2000, 79:216-9.
13. Uchida H, Maruyama T, Ono M. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology. 2007, 148:896-902.
14. Song M, Ramaswamy S, Ramachandran S. Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci USA. 2001, 98:9265-70.
15. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007, 445:851-7.
16. Miller AJ, Mihm MC. Melanoma. N Engl J Med. 2006, 355:51-65.
17. Riker AI, Panelli MC, Kammula US. Development and characterization of melanoma cell lines established by fine needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma. Can Detect and Prev. 1999, 23:387-96.
18. Riker AI. The isolation and culture of melanoma cell lines. Cancer cell culture: methods and protocols 2004, 93-100. Langdon S. In, editor, Totowa, Humana Press, pp
19. Ren SP, Wu CT, Huang WR. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro. Cancer Immunol Immunother. 2006, 55:375-85.
20. Mbeunkui F, Metge BJ, Shevde LA. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res. 2007, 6:2993-3002.
21. Mitra A, Fillmore RA, Metge BJ. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res 2008, 10:R22.
22. Bauer NN, Chen YW, Samant RS. Rac1 activity regulates proliferation of aggressive metastatic melanoma. Exp Cell Res. 2007, 313:3832-9.
23. Riker AI, Enkemann SA, Fodstad O. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics. 2008, 1:13-28.
24. Ren S, Liu S, Howell PM. Identification of a putative oncogene in human melanoma: progestagen-associated endometrial protein. Ann Surg Oncol 2008, 15:10.
25. Morris HR, Dell A, Easton RL. Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem. 1996, 271:32159-67.
26. Dell A, Morris HR, Easton RL. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem. 1995, 270:24116-26.
27. Julkunen M, Seppälä M, Jänne OA. Complete amino acid sequence of human placental protein 14: a progesterone-regulated uterine protein homologous to beta-lactoglobulins. Proc Natl Acad Sci USA. 1988, 85:8845-9.
28. Van Blokl R, Van der Geest N, Mol JNM. Transgene-mediated suppression of chalcone synthase expression in Petunia hybrida results from an increase in RNA turnover. Plant J. 1994, 6:861-77.
29. Fire A, Xu S, Montgomery MK. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998, 391:806-11.
30. Whither RNAi?. Nat Cell Biol. 2003, 5:489-90. Editorial
31. Sledz CA, Holko M, de Veer MJ. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 2003, 5:834-9.
32. Ren S, Liu S, Howell P. The impact of genomics in understanding human melanoma progression and metastasis. Cancer Control. 2008, 15:202-15.
33. Haqq C, Nosrati M, Sudilovsky D. The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA. 2005, 102:6092-7.
34. Winnepenninckx V, Lazar V, Michiels S. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst. 2006, 98:472-82.
35. Seppälä M, Koistinen H, Koistinen R. Glycodelin in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol. 2009, 160:121-33.
36. Hautala LC, Koistinen R, Seppälä M. Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer. 2008, 123:2279-84.
37. Yao MC, Fuller P, Xi X. Programmed DNA deletion as an RNA-guided system of genome defense. Science. 2003, 300:1581-4.
38. Verdel A, Jia S, Gerber S. RNAi-mediated targeting of heterochromatin by the RITS complex. Science. 2004, 303:672-6.
39. Freedman VH, Shin SI. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 1974, 3:355-9.
40. Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol. 2007, 3:655-64.